FN2 Earnings Intelligence
Thermo Fisher Scientific Inc. ratios (quarterly)
Thermo Fisher Scientific Inc. (TMO) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/28/2024 | 3/29/2025 | 6/28/2025 | 9/27/2025 | 3/28/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $4,645 | $4,134 | $4,576 | $1,982 | $3,254 |
| + Debt | $39,229 | $36,808 | $37,247 | $39,307 | $46,037 |
| Enterprise Value | - | - | - | - | - |
| Revenue | $10,598 | $10,364 | $10,855 | $11,122 | $11,005 |
| % Growth | - | - | - | - | - |
| Gross Profit | $7,428 | $5,940 | $6,172 | $6,500 | $6,248 |
| % Margin | 70.1% | 57.3% | 56.9% | 58.4% | 56.8% |
| EBITDA | - | $1,992 | $2,090 | $2,168 | $2,169 |
| % Margin | - | 19.2% | 19.3% | 19.5% | 19.7% |
| Net Income | $1,629 | $1,511 | $1,617 | $1,616 | $1,651 |
| % Margin | 15.4% | 14.6% | 14.9% | 14.5% | 15.0% |
| Diluted EPS | $4.25 | $3.98 | $4.28 | $4.27 | $4.43 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | - | $723 | - | - | $1,192 |
| CapEx | - | $362 | - | - | $376 |
| Free Cash Flow | - | $361 | - | - | $816 |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/28/2024 | 3/29/2025 | 6/28/2025 | 9/27/2025 | 3/28/2026 |
|---|---|---|---|---|---|
| Revenue | $10,598 | $10,364 | $10,855 | $11,122 | $11,005 |
| Gross Profit | $7,428 | $5,940 | $6,172 | $6,500 | $6,248 |
| EBITDA | - | $1,992 | $2,090 | $2,168 | $2,169 |
| Net Income | $1,629 | $1,511 | $1,617 | $1,616 | $1,651 |
| Diluted EPS | $4.25 | $3.98 | $4.28 | $4.27 | $4.43 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/28/2024 | 3/29/2025 | 6/28/2025 | 9/27/2025 | 3/28/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4,645 | $4,134 | $4,576 | $1,982 | $3,254 |
| Short-term Debt | $4,116 | $2,819 | $2,214 | $3,823 | $3,090 |
| Long-term Debt | $35,113 | $33,989 | $35,033 | $35,484 | $42,947 |
| Total Debt | $39,229 | $36,808 | $37,247 | $39,307 | $46,037 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/28/2024 | 3/29/2025 | 6/28/2025 | 9/27/2025 | 3/28/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $723 | - | - | $1,192 |
| Capital Expenditure | - | $362 | - | - | $376 |
| Free Cash Flow | - | $361 | - | - | $816 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/28/2024 | 3/29/2025 | 6/28/2025 | 9/27/2025 | 3/28/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 70.1% | 57.3% | 56.9% | 58.4% | 56.8% |
| EBITDA Margin | - | 19.2% | 19.3% | 19.5% | 19.7% |
| Net Margin | 15.4% | 14.6% | 14.9% | 14.5% | 15.0% |
| FCF Margin | - | 3.5% | - | - | 7.4% |
| Diluted EPS Growth | - | - | - | - | - |